Terri Lynn Parker, MD

Assistant Professor of Medicine (Hematology); Assistant Professor

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: Not Applicable

Patient Care Organizations

Hematology

Cancer Center: Hematology Program

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Internal Medicine AB of Internal Medicine (2008)

  • Hospice & Palliative Medicine AB of Internal Medicine (2010)

  • Hematology (Internal Medicine) AB of Internal Medicine (2012)

  • Medical Oncology AB of Internal Medicine (2013)

Clinical Trials

Conditions Study Title
Multiple Myeloma An Open-Label, Randomized Phase 3 Trial of Combinations of Nivolumab, Elotuzumab, Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma- CheckMate 602: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 602
Leukemia, other, Phase I A Phase I Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia
Myeloid and Monocytic Leukemia An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects
Hodgkin's Lymphoma, Leukemia, other, Multiple Myeloma, Non-Hodgkin's Lymphoma, Other Hematopoietic, Phase I An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
Multiple Myeloma A Study of MPDL3280A (Anti-Programmed Death Ligand 1 [PD-L1] Antibody) Administered With or Without Lenalidomide in Patients With Multiple Myeloma (MM)
Multiple Myeloma Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

Edit this profile

Contact Info

Terri Lynn Parker, MD
Patient Care Location
Yale Cancer CenterSmilow Cancer Hospital at Yale - New Haven
35 Park Street, Ste North Pavilion 7

New Haven, CT 06511
View on map...
Mailing Address
PO Box 208028
New Haven, CT 06520-8021